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Abstract 
Purpose: The most important prognostic variable for early stage breast cancer is the status of axillary lymph nodes. 
The aim of this study was to evaluate the diagnostic accuracy of preoperative magnetic resonance imaging (MRI) for 
metastatic axillary lymph node in breast cancer cases with post-operative sentinel lymph node biopsy (SLNB) results.
Materials and methods: Women aged between 21 and 73 years who were diagnosed with malignant mass lesion 
of the breast between 2013 and 2015 were included in this study. The preoperative MR images of patients with 
diagnosis of breast cancer was evaluated to determine axillary lymph node status. Axillary lymph node size, long axis 
to short axis ratio, lymph node contours, cortical thickness to anteroposterior diameter ratio, the presence of a fatty 
hilum and contrast enhancement patterns (homogenous or heterogenous) was noted. Additionally, the presence 
of comet tail sign which a tail extending from an enhancing breast lesion into the parenchyma and might represent 
ductal infiltration on post-contrast series was also noted. All data obtained from this evaluation was compared with 
postoperative SLNB results.
Results: Metastatic nodes were found to have a longer short axis when compared to reactive nodes (p = 0.042; 
p < 0.05). The long axis to short axis ratio was notably lower in metastatic nodes when compared to reactive nodes. 
Cortical thickness was higher in metastatic nodes when compared to reactive nodes (p = 0.024; p < 0.05). Comet sign 
was observed in 15 of metastatic nodes (73.3 %) and in one (5 %) reactive node. This difference was statistically signifi-
cant (p = 0.001; p < 0.01). While fatty hilum was seen in 40 % of metastatic nodes (n = 6), it was seen in all (n = 20) 
reactive nodes. This difference was statistically significant (p = 0.001; p < 0.01).
Conclusions: MRI is a non invasive sensitive and specific imaging modality for evaluating the axilla. We have shown 
that with the help of comet tail sign and status of fatty hilum contrast enhanced MRI has the highest sensitivity of 
84.7 % for detecting axillary lymph node metastases (Singletary et al. in Semin Surg Oncol 21(1):53–59, 2003).
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Background
Breast cancer is the most commonly observed malig-
nancy in women (Siegel et al. 2012). Magnetic resonance 
imaging (MRI) can evaluate the breasts and breast can-
cer related areas such as axillary lymph nodes, skin or 
pectoral muscle that are important for prognosis. Prog-
nostic factors for breast cancer are axillary lymph node 
status, tumour diameter, tumour type/grade, lymphatic 
and vascular invasion, proliferation markers, ethnicity 
and patients’ age at diagnosis (Cianfrocca and Goldstein 
2004). The most important prognostic variable for early 
stage breast cancer is the status of axillary lymph nodes. 
There is a correlation between the number of involved 
axillary lymph nodes and the risk of distant recurrence 
(Saez et al. 1989; Nemoto et al. 1983).
The status of lymph nodes in patients with breast 
cancer used to be evaluated with axillary lymph node 
dissection (ALND). During the last 15  years. Senti-
nel lymph node biopsy (SLNB) has replaced ALND for 
grading of patients with clinically lymph node negative 
breast cancer. Despite being a less invasive method when 
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compared to ALND, SLNB leads to complications such 
as lymphedema, seroma, localised swelling, pain, par-
aesthesia, decrease in arm strength, infectious neuropa-
thy and shoulder stiffness in 20  % of patients (Giuliano 
et  al. 2000). 60–70  % of newly diagnosed patients have 
negative lymph nodes (Kell and Kerin 2004). Therefore 
this group of patients do not benefit from SLNB, yet are 
put under the short and long term morbidity risks of 
this procedure (Cady et al. 1996). This morbidity may be 
eliminated through the use of non-invasive techniques. 
However the detection of small metastasis with these 
methods may be difficult. The American Joint Commit-
tee on Cancer (AJCC) defines micrometastasis (pNmi) 
as metastatic lymph nodes with a maximum diameter of 
0.2–2 mm and isolated tumour cells (ITCs) [pN0(i+)] as 
a lesion of tumour cells smaller than 0.2 mm in diameter 
or small cell clusters (Singletary et  al. 2003). Microme-
tastasis and isolated tumour cells do not effect general 
survival. Therefore, the sensitivity for their detection is of 
less importance (Maaskant-Braat et al. 2011).
In recent years non-invasive methods such as ultra-
sonography (US) and positron emission tomography–
computed tomography (PET–CT) have been suggested 
for the evaluation of the axilla. MR imaging has several 
advantages over other imaging modalities such as not 
utilizing ionizing radiation (when compared to PET) and 
having low intra and interobserver differences (when 
compared to US).
The aim of this study was to evaluate the diagnostic 
accuracy of preoperative conventional magnetic reso-
nance imaging (MRI) for metastatic axillary lymph node 
in breast cancer cases with post-operative sentinel lymph 
node biopsy (SLNB) results.
Methods
This prospective study was conducted at a tertiary uni-
versity hospital. 35 women aged between 21 and 73 years 
who were diagnosed with malignant mass lesion of the 
breast between 2013 and 2015 were included in this 
study. Institutional ethics committee approved the study 
and signed informed consent was obtained from all 
participants.
MR imaging method
The axillas were scanned by a 1.5-T MR scanner (Intera. 
Philips Medical Systems. Best. The Netherlands) using 
a dedicated double-breast surface coil with the patient 
in the prone position. An axial three-dimensional high-
resolution T1-weighted fast gradient echo fat-suppressed 
sequence [TE/TR 2.4/4.6  ms; inversion delay spectral 
presaturation attenuated by inversion recovery (SPAIR) 
90 ms; flip angle 10°; FOV 360 × 360 × 132 mm3 acquired 
voxel size 0.9 × 0.9 × 2.5 mm3 reconstructed voxel size 
0.83 × 0.83 × 2.50 mm3. Total acquisition time 60 s] was 
performed before administration of contrast agent, fol-
lowed by repeat performance of this same sequence at 
0, 1, 2, 3, 4, 5 and 7 min after administration of contrast 
agent. An additional axial T2-weighted fat suppressed 
spin echo sequence (TE/TR 110/7548 ms; inversion delay 
SPAIR 80 ms; flip angle 90°; FOV 380 × 380 × 155 mm3, 
acquired voxel size 1.06 × 1.74 × 3.0 mm3, reconstructed 
voxel size 0.94 × 0.94 × 3.00 mm3, total acquisition time 
242  s) was performed before administration of contrast 
material. Postcontrast three-dimensional T1-weighted 
fast gradient-echo dynamic MR images were acquired 
after administration of 0.1 mmol/kg gadolinium diethyl-
enetriaminepentaacetic acid (Gd-DTPA).
The preoperative MR images of patients with diagno-
sis of breast cancer was evaluated to determine axillary 
lymph node status. Axillary lymph node size, long axis to 
short axis ratio, cortical thickness to anteroposterior (AP) 
diameter ratio, the presence of a fatty hilum (Fig. 1a) and 
contrast enhancing patterns (homogenous or heteroge-
nous) on postcontrast series was noted. Additionally, the 
presence of a comet tail sign on post-contrast series was 
also noted (Fig.  1b). Comet tail sign was first described 
for breast lesions by Kaiser (2008). It is a tail extending 
from an enhancing breast lesion into the parenchyma. 
The tail is usually directed towards nipple or the ductal 
Fig. 1 a Axial T2WS-TSE MRI showing an enlarged lymph node on 
the right axilla. Fatty hilum is absent with an increased asymmetrical 
cortical thickness. b The lymph node has a small tail on axial post 
contrast T1WS MRI, this is called “comet tail sign”
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system. This sign might represent ductal infiltration or 
angiogenesis. It is actually used for breast lesions but we 
have used this sign for lymph nodes for the first time. For 
lymph nodes we did not expect long comet tails but small 
irregularities of the nodes after contrast enhancement 
was also noted as tail sign.
While some previous studies (Memarsadeghi et  al. 
2006) have evaluated only the largest lymph node, we 
especially evaluated nodes where fatty hilum was not 
observed and comet tail sign was positive. We chose the 
most suspicious lymph node regardless of its size, as the 
representative lymph node. MR images of lymph nodes 
were evaluated by two radiologists, one of which was a 
breast radiologist. If the results differed then the images 
were re-evaluated and a consensus was reached. All data 
obtained from this evaluation was compared with post-
operative SLNB results.
Statistical analyses
Statistical analyses was performed using Number 
Cruncher Statistical System (NCSS) 2007 (Kaysville, UT, 
USA). Apart from descriptive statistical methods (aver-
age, standard deviation, median, frequency, rate, mini-
mum, maximum) quantitative data was compared using 
Student’s t test when variables showed normal distribu-
tion and Mann–Whitney U test when variables were not 
distributed normally. Qualitative data was compared 
using Fisher’s exact test. Yates continuity correction test 
(Yates correction Chi Square) and diagnostic screening 
tests were used (specificity, sensitivity etc.). Statistical 
significance was evaluated at p < 0.01 and p < 0.05.
Results
Mean age of women was 52.86 ± 13.24. There was no sta-
tistical difference between the ages of patients for those 
with reactive lymph nodes versus those with metastatic 
nodes (p > 0.05).
Metastatic lymph node was observed as invasive ductal 
carcinoma metastasis in 85.7 % (n = 30), invasive lobu-
lar carcinoma metastasis in 8.6 % (n = 3) and medullary 
carcinoma metastasis in 5.7  % (n =  2) patients. Lymph 
nodes were smooth contoured in 85.7 % (n = 30), irregu-
lar contoured in 14.3 % (n = 5). Their echogenicity was 
homogeneous in 85.7  % (n  =  30) and heterogenous in 
14.3 % (n = 5).
The long axis measurements of lymph nodes ranged 
from 4 to 28  mm (average 12.37 ±  5.78  mm) while the 
short axis measurements ranged from 2 to 19 mm (aver-
age 6.94  ±  3.62  mm). The long axis to short axis ratio 
ranged from 1 to 4.6 (average 1.91 ± 0.72). While there 
was no statistically significant correlation between the 
long axis measurement and whether the node was reac-
tive or metastatic; metastatic nodes were found to have 
a longer short axis when compared to reactive nodes 
(p = 0.042; p < 0.05). The long axis to short axis ratio was 
notably lower in metastatic nodes when compared to 
reactive nodes. although this was not statistically signifi-
cant (p = 0.071; p > 0.05).
Cortical thickness ranged from 1 to 9  mm (average 
3.25 ± 2.16 mm) and the cortical thickness to AP diam-
eter ratio ranged from 0.18 to 0.90 (average 0.46 ± 0.17). 
Cortical thickness was higher in metastatic nodes 
when compared to reactive nodes (p =  0.024; p  <  0.05) 
(Table 1). There was no statistically significant difference 
between reactive or metastatic nodes with regards to cor-
tical thickness to AP diameter ratio (p > 0.05).
Comet tail sign was observed in 15 of metastatic nodes 
(73.3 %) and in one (5 %) reactive node. This difference 
was statistically significant (p  =  0.001; p  <  0.01). The 
Odds ratio was calculated as 52.250 (95  % CI 5.167–
528.342). The sensitivity, specificity and accuracy was 
calculated as 73.33, 95 and 86.71  % respectively. Posi-
tive predictive value was 91.67 % and negative predictive 
value was 82.61 % (Table 2).
While fatty hilum was seen in 40  % of metastatic 
nodes (n = 6), it was seen in all (n = 20) reactive nodes. 
This difference was statistically significant (p  =  0.001; 
p  <  0.01). The sensitivity specificity and accuracy was 
60 %. 100 and 82.86 %, respectively. The positive predic-
tive value was 100  % and negative predictive value was 
76.92 % (Table 3).
Discussion
Nowadays, fewer modified radical mastectomies are 
being planned in the surgical treatment of breast cancer 
and breast sparing surgery has become the treatment of 
choice. Similar approaches are taken for the axilla and 
unnecessary axillar dissections are avoided. No doubt, 
this change has been brought about by commonly seen 
complications after axillary dissection, such as pain, 
edema, neuropathy, long hospital stay and prolonged 
wound healing.
The axilla, is the most common area of metastasis for 
breast cancer (Kvistad et al. 2000). The presence of axil-
lary metastasis is important for prognosis and deter-
mining the treatment plan. Nowadays, SLNB is used to 
determine the status of axillary lymph nodes. While a 
positive SLNB leads to axillary dissection, a negative 
SLNB saves the patient from further dissection and its 
related complications (Hyun et al. 2016). However, even 
this approach can be considered invasive. There are 
several studies regarding ideal and non-invasive imag-
ing techniques for the detection of axillary lymph node 
status, such as ultrasound, ultrasound guided fine nee-
dle aspiration, PET–CT, contrast-enhanced MRI, ultra-
small super-paramagnetic iron oxide (USPIO)-MRI 
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Table 1 Evaluation of pathological status of axillary lymph nodes
* p < 0.05; ** p < 0.01
a Student t test
b Mann–Whitney U test
c Yates continuity correction test
d Fisher’s exact test
Pathological status p
Metastatic (n = 15) Reactive (n = 20)
Age
 Average ± SD 51.8 ± 14.82 53.65 ± 12.27 0.689a
 Min–Max 26–80 (49) 35–73 (54)
Long axis (mm)
 Average ± SD 12.67 ± 5.05 12.15 ± 6.38 0.798a
 Min–Max 6–22 (12) 4–28 (9.5)
Short axis (mm)
 Average ± SD 8.00 ± 3.34 6.15 ± 3.70 0.042*,b
 Min–Max 2–14 (8) 2–19 (5)
Long/short axis
 Average ± SD 1.69 ± 0.64 2.07 ± 0.76 0.071b
 Min–Max 1–3 (1.5) 1.3–4.6 (1.8)
Cortical thickness (mm)
 Average ± SD 4.11 ± 2.30 2.60 ± 1.84 0.024*,b
 Min–Max 1.2–9 (3) 1–9 (2)
Cortical thickness/AP diameter
 Average ± SD 0.51 ± 0.21 0.42 ± 0.13 0.167a
 Min–Max 0.22–0.9 (0.6) 0.18–0.7 (0.41)
n (%) n (%)
Comet tail sign
 Present 11 (73.3) 1 (5.0) 0.001**,c
 Not present 4 (26.7) 19 (95.0)
Fatty hilum
 Not present (obscured) 9 (60.0) 0 (0.0) 0.001**,d
 Present (intact) 6 (40.0) 20 (100.0)




n % n % n %
Comet tail sign
 Present 11 31.4 1 2.9 12 34.3 0.375
 Not present 4 11.4 19 54.3 23 65.7
 Total 15 42.9 20 57.1 35 100
Sensitivity (%) 73.33
Specificity (%) 95.00
Positive predictive value (%) 91.67
Negative predictive value (%) 82.61
Accuracy (%) 85.71
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and diffusion-weighted MRI. Due to user dependence, 
ultrasound guided fine needle aspiration biopsy has a 
wide sensitivity range, that is reported to be between 
25 and 97 % (Bedrosian et al. 2003; Sahoo et al. 2007). 
Previous studies have noted that while US make the 
distinction between N0 and N1 for lymph node stag-
ing, it cannot distinct between N2 and N3 (Hyun et al. 
2016; van Schipper et  al. 2013; Caudle et  al. 2014). 
Comparison of PET–CT and MRI have concentrated 
more on MRI, due to the use of ionizing radiation in 
PET–CT (Meng et  al. 2011). While these methods are 
unable to detect micrometastasis, micrometastasis are 
known not to effect survival (Kuijs et  al. 2015). In a 
study by Guiliano et  al. on patients with limited axil-
lary metastasis, no significant difference in survival was 
found between patients undergoing ALND and those 
not (Giuliano et al. 2011).
Mortorello et al. reported a statistically significant cor-
relation between metastasis on pathology and the pres-
ence of a single or multiple nodes with no fatty hilum in 
contrast enhanced MRI. The same study reported no cor-
relation between pathological lymph node positivity and 
contrast enhancing kinetics, number of lymph nodes or 
lymph node sizes (Mortellaro et al. 2009). Our study also 
found significant correlation between no fatty hilum and 
metastatic lymph nodes.
Luciani et  al. reported that small axis length >4  mm 
as a predictive value. The presence of cortical irregu-
larities and cortical thickness of >3 mm was found to be 
statistically significantly correlated with the presence of 
metastatic lymph nodes (Luciani et  al. 2009). When we 
compared reactive and metastatic nodes, we also found 
that cortical thickness was higher in metastatic lymph 
nodes.
It has been reported that metastatic lymph nodes have 
similar contrast enhancement kinetics with primary 
breast masses on MRI, and that metastatic lymph nodes 
demonstrate wash-out similar to malignant lesions (Kvis-
tad et al. 2000). This can be explained through aggressive 
neoangiogenesis and increased capillary permeability. 
We, therefore believe that imaging findings of malignant 
breast masses on postcontrast images may be beneficial 
in determining the metastatic status of axillary lymph 
nodes. We evaluated the presence of comet tail sign in 
metastatic lymph nodes. To our knowledge such a cor-
relation has not been previously investigated. Our study 
found that of 15 pathologically confirmed metastatic 
nodes 11 had comet tail sign, while only 1 of 20 reactive 
nodes showed the same sign. We therefore believe that 
this may be important for the evaluation of metastatic 
status of axillary nodes.
A systematic review published in 2015 by Kuijs et  al. 
included 60 studies and no clear number was given for 
the number of metastatic lymph nodes on axillary MRI 
(Kuijs et al. 2015). In order for axillary MRI to routinely 
and safely replace SLNB, each lymph node must be evalu-
ated as metastatic or reactive. Many studies are required 
for this purpose. When individually evaluating pathologi-
cal nodes, many specific findings may be required. At this 
point, we believe that a positive comet tail sign in patho-
logically confirmed metastatic node is an important and 
strong finding.
Our study has some limitations. MR evaluations were 
performed without using an axillary coil, which led to 
limited evaluation of the axillary anatomy. Also our 
patient population is relatively small. We did not use 
diffusion MRI which is also a promising method for the 
differential diagnosis between metastatic and benign 





n % n % n %
Fatty hilum
 Present (intact) 9 25.7 0 0 9 25.7 0.031*
 Not present (obscured) 6 17.1 20 57.1 26 74.3
 Total 15 42.9 20 57.1 35 100.0
Sensitivity for malignant lymph nodes (%) 60.00
Specificity for malignant lymph nodes(%) 100.00
Positive predictive value for malignant lymph nodes(%) 100.00
Negative predictive value for malignant lymph nodes(%) 76.92
Accuracy (%) for detecting malignant lymph nodes(%) 82.86
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axillary lymph nodes (Fornasa et  al. 2012; Yamaguchi 
et  al. 2015; Chung et  al. 2014). Our method might be 
combined with diffusion weighted MRI for better results. 
Minimally invasive approaches are being preferred for 
the treatment of breast cancers. MRI is superior to other 
imaging modalities when evaluating the axilla, and has 
the highest sensitivity of 84.7 % (Kuijs et al. 2015). Similar 
studies are required to gather further evidence of specific 
imaging findings in metastatic lymph nodes.
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